RIPK2-IN-8

CAS No. 2141969-56-2

RIPK2-IN-8( RIPK2-IN-8 | RIPK2 IN 8 | RIPK2IN8 | RIPK2 inhibitor 8 )

Catalog No. M13424 CAS No. 2141969-56-2

A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 337 Get Quote
50MG 1674 Get Quote
100MG 2538 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RIPK2-IN-8
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM.
  • Description
    A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM; displays 90% percent of kinases showed <50% inhibition in a broad 250 kinase panel; effectively suppresses IL6 secrection in mouse bone marrow derived macrophages with IC50 of 12 nM; significantly reverses MDP-induced pro-inflammatory cytokines in rat colon.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RIPK2-IN-8 | RIPK2 IN 8 | RIPK2IN8 | RIPK2 inhibitor 8
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2141969-56-2
  • Formula Weight
    392.449
  • Molecular Formula
    C18H21FN4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (79.63 mM)
  • SMILES
    NC1=NC(F)=CC(C2=CN=C3C=C(OCC)C(S(=O)(C(C)(C)C)=O)=CN32)=C1
  • Chemical Name
    4-(6-(tert-butylsulfonyl)-7-ethoxyimidazo[1,2-a]pyridin-3-yl)-6-fluoropyridin-2-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. He X, et al. ACS Med Chem Lett. 2017 Sep 27;8(10):1048-1053.
molnova catalog
related products
  • Necrostatin 2 racema...

    Necrostatin 2 racemate is an potent and specific inhibitor of?RIPK1.

  • GSK547

    GSK547 (RIP1i, GSK 547) is a highly selective and potent inhibitor of RIP1 kinase that robustly targets RIP1 in vivo.

  • CSLP37

    CSLP37 (RIPK2 inhibitor CSLP37) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 16.3 nM in ADPGlo assay.